Kinghorn Cancer Centre; St Vincents Hospital
Darlinghurst, New South Wales, Australia
Cancer treatment center in Darlinghurst, New South Wales
370 Victoria St, Darlinghurst NSW 2010
About Kinghorn Cancer Centre; St Vincents Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
6
Arcus Biosciences, Inc.
3
Genentech, Inc.
2
Bayer
1
OncoMed Pharmaceuticals, Inc.
1
Shanghai Henlius Biotech
1
Clinical Trials at Kinghorn Cancer Centre; St Vincents Hospital
During the past decade, Kinghorn Cancer Centre; St Vincents Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants
2014-08-19
2026-09-29
Active, not recruiting
303
A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer
2015-02-01
2017-04-07
Completed
82
A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)
2014-11-12
2017-03-13
Completed
334
Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors
2016-05-23
2024-10-05
Active, not recruiting
518
Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors
2017-05-26
2021-07-26
Completed
173
A Phase 1 Study of HLX20, a Human Monoclonal Antibody Targeting PD-L1Protein in Patients With Advanced Solid Tumors
2018-08-07
2021-06-28
Completed
26
A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies
2018-09-12
2024-02-01
Active, not recruiting
75
A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies
2018-10-15
2021-07-02
Completed
35
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kinghorn Cancer Centre; St Vincents Hospital" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Arcus Biosciences, Inc." with 3 trials
sponsored, "Genentech, Inc." with 2 trials sponsored, "Bayer" with 1 trials sponsored and "OncoMed Pharmaceuticals, Inc."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kinghorn Cancer Centre; St Vincents Hospital"
#1 collaborator was "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "ImmunoGen, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Kinghorn Cancer Centre; St Vincents Hospital
According to Clinical.Site data, the most researched conditions in "Kinghorn Cancer Centre; St Vincents Hospital" are
"Breast Cancer" (3 trials), "Ovarian Cancer" (2 trials), "Advanced Solid Tumors" (1 trials), "Advanced/Metastatic Tumors" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Kinghorn Cancer Centre; St Vincents Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kinghorn Cancer Centre; St Vincents Hospital
Most popular intervention types in "Kinghorn Cancer Centre; St Vincents Hospital" are "Drug" (14 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Alectinib" (2 trials), "Carboplatin" (2 trials), "Cisplatin" (2 trials) and "Giredestrant" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Kinghorn Cancer Centre; St Vincents Hospital
The vast majority of trials in "Kinghorn Cancer Centre; St Vincents Hospital" are
12 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Kinghorn Cancer Centre; St Vincents Hospital
Currently, there are NaN active trials in "Kinghorn Cancer Centre; St Vincents Hospital".
undefined are not yet recruiting,
2 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Kinghorn Cancer Centre; St Vincents Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kinghorn Cancer Centre; St Vincents Hospital, 7 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Kinghorn Cancer Centre; St Vincents Hospital
Kinghorn Cancer Centre; St Vincents Hospital has several departments that took part in Clinical trials: "Kinghorn Cancer Centre, St. Vincent's Hospital" - 4 trials
Departments List
Name
City
Trials